LXR Protein (Liver X Receptor)

LXR Protein (Liver X Receptor)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LXR Protein (Liver X Receptor)</th>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">LXRα</td>
<td>NR1H3</td>
</tr>
<tr>
<td class="label">LXRβ</td>
<td>NR1H2</td>
</tr>
<tr>
<td class="label">Gene Variant</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">NR1H3 (LXRα) variants</td>
<td>Altered activity</td>
</tr>
<tr>
<td class="label">NR1H2 (LXRβ) variants</td>
<td>Modified function</td>
</tr>
<tr>
<td class="label">ABCA1 variants</td>
<td>Cholesterol efflux</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">RXR</td>
<td>Heterodimer formation</td>
</tr>
<tr>
<td class="label">PGC-1α</td>
<td>Coactivator</td>
</tr>
<tr>
<td class="label">NCoR/SMRT</td>
<td>Corepressor</td>
</tr>
<tr>
<td class="label">ABCA1</td>
<td>Target gene</td>
</tr>
<tr>
<td class="label">APOE</td>
<td>Target gene</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>

LXR Protein (Liver X Receptor)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LXR Protein (Liver X Receptor)</th>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">LXRα</td>
<td>NR1H3</td>
</tr>
<tr>
<td class="label">LXRβ</td>
<td>NR1H2</td>
</tr>
<tr>
<td class="label">Gene Variant</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">NR1H3 (LXRα) variants</td>
<td>Altered activity</td>
</tr>
<tr>
<td class="label">NR1H2 (LXRβ) variants</td>
<td>Modified function</td>
</tr>
<tr>
<td class="label">ABCA1 variants</td>
<td>Cholesterol efflux</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">RXR</td>
<td>Heterodimer formation</td>
</tr>
<tr>
<td class="label">PGC-1α</td>
<td>Coactivator</td>
</tr>
<tr>
<td class="label">NCoR/SMRT</td>
<td>Corepressor</td>
</tr>
<tr>
<td class="label">ABCA1</td>
<td>Target gene</td>
</tr>
<tr>
<td class="label">APOE</td>
<td>Target gene</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>

Liver X receptors (LXRs) are nuclear receptors that function as master regulators of cholesterol homeostasis and lipid metabolism[@zelcer2005]. There are two LXR isoforms: LXRα (NR1H3) and LXRβ (NR1H2), which are ligand-activated transcription factors that sense oxysterols and regulate genes involved in cholesterol efflux, metabolism, inflammation, and brain function[@nagai2005]. LXRs have emerged as important therapeutic targets for neurodegenerative diseases due to their ability to modulate cholesterol metabolism, reduce neuroinflammation, and promote amyloid clearance in the brain[@wang2006].

Protein Structure

LXR proteins have the typical nuclear receptor architecture:

Isoforms

Domain Architecture

LXR Protein Structure
┌────────────────────────────────────────────────────────┐
│ AF-1 │ DBD │ Hinge │ LBD │ AF-2 │
│ (1-120) │(121-200)│ (201-260) │ (261-420) │(421-447)│
└────────────────────────────────────────────────────────┘

DBD: DNA-binding domain (zinc fingers)
LBD: Ligand-binding domain (hydrophobic pocket)
AF: Activation function

• N-terminal AF-1 Domain: Variable, confers isoform-specific transcriptional activation
• DNA-binding Domain (DBD): Contains two C4-type zinc fingers that bind to DR-4 response elements
• Hinge Region: Flexible linker allowing conformational changes
• Ligand-binding Domain (LBD): Hydrophobic pocket binds oxysterols and synthetic agonists
• AF-2 Region: Helix 12 that completes the agonist-bound conformation

Normal Biological Function

Cholesterol Metabolism Regulation

LXRs are the body's primary cholesterol sensors:

• Activate ABCA1: Promotes [ApoE](/proteins/apoe) lipidation and cholesterol efflux to ApoA1
• Activate ABCG1: Mediates cholesterol efflux to HDL
• Activate ABCG4: Brain-specific cholesterol efflux

• Regulate APOE expression in brain
• Control CYP7A1 (cholesterol 7α-hydroxylase) in liver
• Modulate LDL receptor expression

Anti-inflammatory Effects

LXRs have profound anti-inflammatory properties:

• Transrepression: Inhibit [NF-κB](/entities/nf-kb) transcription without DNA binding
• COX-2 Suppression: Reduce prostaglandin synthesis
• iNOS Inhibition: Decrease nitric oxide production
• Cytokine Regulation: Modulate IL-1β, TNF-α, IL-6 expression

Lipid Metabolism

• Fatty Acid Synthesis: Activate SREBP-1c for lipogenesis
• Triglyceride Regulation: Modulate lipogenic gene expression
• Phospholipid Metabolism: Control lipid composition

Role in Neurodegeneration

Alzheimer's Disease

LXRs are particularly important in AD pathogenesis:

Amyloid Pathology:

• LXR agonists reduce amyloid-β deposition in mouse models[@van2019]
• ABCA1/LXR pathway affects APOE lipidation and [Aβ](/proteins/amyloid-beta) clearance
• Enhanced microglial cholesterol efflux reduces amyloid burden

• LXR activation improves memory in AD models
• Synaptic protection through cholesterol regulation
• Neuroinflammatory reduction

• LXR agonists (GW3965, T0901317) show promise in preclinical studies
• Selective LXRβ agonists avoid peripheral side effects
• ABCA1 activators as alternative approach

Parkinson's Disease

LXR activation provides neuroprotection in PD:

Dopaminergic Neuron Protection:

• Reduced oxidative stress in substantia nigra
• Enhanced mitochondrial function
• Anti-apoptotic effects

• Suppression of microglial activation
• Reduced dopaminergic neuron loss
• Modulation of glial cell function

• LXR agonists protect against MPTP toxicity
• GW3965 reduces neuroinflammation
• Combined approach with L-DOPA

Amyotrophic Lateral Sclerosis

• Modulation of lipid metabolism in motor [neurons](/entities/neurons)
• Anti-inflammatory effects
• Energy metabolism support

Frontotemporal Dementia

• Cholesterol regulation in neurons
• Neuroinflammatory pathways
• Lipid droplet metabolism

Genetic Associations

Protein Interactions

Transcriptional Complexes

Signaling Cross-talk

• PPAR Pathway: Cross-activation with PPARγ
• SREBP Pathway: Coordinate lipid regulation
• NF-κB: Reciprocal repression

Expression Patterns in the Brain

Cellular Distribution

• Neurons: High expression, particularly in [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)
• [Astrocytes](/entities/astrocytes): Moderate to high expression
• [Microglia](/cell-types/microglia-neuroinflammation): LXRβ predominant, increases with activation
• Oligodendrocytes: Lower expression

Regulation

• Ligand-dependent: Activated by oxysterols
• Cholesterol levels: Feedback regulation
• Inflammatory signals: NF-κB suppresses LXR activity

Therapeutic Implications

Synthetic LXR Agonists

• Good brain penetration
• Reduces amyloid pathology
• Improves cognition

• Strong cholesterol efflux effect
• Liver toxicity concerns

• Reduced liver side effects
• Clinical trials for atherosclerosis

Challenges and Solutions

• Peripheral Side Effects: Selective LXRβ agonists
• Lipogenesis: Tissue-specific delivery
• Brain Penetration: Optimized compounds

Alternative Approaches

• ABCA1 Direct Activators: Avoid LXR side effects
• Gene Therapy: Target ABCA1 expression
• APOE Modulators: Enhance lipidation

Related Pathways

• [Cholesterol Metabolism](/data/pages/cerebral_cholesterol_metabolism)
• [APOE and Lipid Metabolism](/mechanisms/apoe-lipid-metabolism)
• [NF-κB Signaling](/mechanisms/nf-kb-signaling-neuroinflammation)
• [Microglial Activation](/mechanisms/microglia-neuroinflammation)
• [Amyloid Clearance](/mechanisms/amyloid-clearance-pathways)

Related Proteins

• [NR1H3 Gene (LXRα)](/genes/nr1h3)
• [NR1H2 Gene (LXRβ)](/genes/nr1h2)
• [ABCA1 Protein](/proteins/abcg1-protein)
• [APOE Protein](/proteins/apoe-protein)
• [RXR Protein](/proteins/rxra-protein)
• [TREM2 Protein](/proteins/trem2-protein)

Pathway & Interaction Diagram

Interactive diagram showing LXR's key relationships in the SciDEX knowledge graph (9 connections shown).

See Also

• [APOE and Lipid Metabolism](/mechanisms/apoe-lipid-metabolism)
• [NF-κB Signaling](/mechanisms/nf-kb-signaling-neuroinflammation)
• [Microglial Activation](/mechanisms/microglia-neuroinflammation)
• [Amyloid Clearance](/mechanisms/amyloid-clearance-pathways)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References